In my latest column for MPO, I discuss the risks new weight-loss drugs (GLP1s) may pose to OEMs and contract manufacturers. Heavy Harm or Slim Chance? The Impact of GLP1s on Medtech The highest existential risk is not to OEMs but to contract manufacturers specializing in the areas where GLP1s will delay surgeries. Read the column here.
News/Reports
A.S. Freeman will be in Anaheim, California for MD&M West 2024, which takes place from February 6-8, as well as for the annual mdmX Networking event Monday February 5. If you would like to meet up in Anaheim, please drop me a line, or give me a call at 917-868-0772.
The Annual mdmX Networking Event is slightly different this year – it will still be the Monday before MD&M West opens, but in a reception format. Please join us for an evening of conversation with other leaders in the medical device supply chain. Join the Conversation 2024 Annual mdmX Networking Reception Anaheim California Monday, February 5, 2024 5:30-8:30pm The Annual mdmX (Medical Device Manufacturers eXchange) Networking Reception returns Monday, February 5, 2024 in Anaheim, California. Join us for cocktails and hors d’oeuvres at McCormick & Schmick’s Grille (321 W Katella Ave., Anaheim, CA 92802) in a relaxed setting with other leaders in the medical device supply chain. As in past years, business owners and senior executives will compare notes, share insights, and talk about the future of the industry. There is no agenda and no pressure. Please come to be part of the conversation. Get your tickets at Eventbrite Click here to add this event to your calendar. What is mdmX? The Medical Device Manufacturers eXchange (mdmX) is an informal association of owners and senior executives of medical device supply chain manufacturers and service providers. We meet annually the evening before the MDM West Expo in Anaheim, California. There are no membership fees or obligations. The purpose of the evening is to create a once-a-year forum for supply chain business leaders to discuss, listen, learn, make new connections, and strengthen old friendships. It is a chance to discuss the bigger issues with those who share your experiences in leading companies in the supply chain.
I am honored to present The State of the Medtech Industry keynote address on October 18th at the MPO Summit in San Diego. I’ll cover the forces changing product lines and potentially introducing new competitors into the medtech supply chain.
I’m pleased to announce A. S. Freeman Advisors’ annual Global Trends in Medtech 2023 is available here for download and distribution. Key points in this year’s presentation include: Medtech market size and growth rate Demographic and economic trends reshaping OEM product lines for the next decades Redefinition of what constitutes a medical device The size and growth rate of the medical device supply chain Changing roles for the contract manufacturing incumbents? Strategies for participating in the digitization of devices and systems As always, I am happy to present Global Trends to you or your firm. Please reach me at tfreeman@asfreeman.com with questions, comments, or requests. Best regards, Tony Freeman
Atalys has acquired precision moldmaker ROMOLD, Inc. of Rochester, New York. A.S. Freeman Advisors, LLC advised ROMOLD on this transaction. For more information please contact Tony Freeman. Anthony S. Freeman A.S. Freeman Advisors, LLC (917) 868-0772 tfreeman@asfreeman.com asfreeman.com
Tony Freeman will be attending MPO Summit 2022 and Device Talks West 2022, and welcomes the opportunity to meet with colleagues. Schedule: MPO Summit in Austin, TX on Tuesday, October 18 – at Austin Marriot Downtown Device Talks West in Santa Clara on WednesdayOctober 19 – at Santa Clara Convention Center Get in touch with me at (917) 878-0772 or by email at tfreeman@asfreeman.com to set up a time to get together.
My latest piece for MPO Magazine discusses business strategies for the medical device supply chain in response to two trends: the rise of reliance on contract manufacturers vs OEMs, and supply chain consolidation.
Two strategies have emerged: the integrated contract manufacturer approach, and the specialist niche approach. I discuss the advantages and disadvantages of each, and opportunities for strategic expansion.